Position
Persistent Asset Partners Ltd in Vaxcyte, Inc.
Back to the book · All holders of PCVX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $63.7K$46.14 → $58.11
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q3 2025 | 50.1K | $1.8M | — | — | — | 1.2% |
| Q4 2025 | 5.33K | $246.1K | $46.14 | $54K | −$1.61M | 0.1% |
| Q1 2026 | 5.32K | $309.1K | $58.11 | $63.7K | −$692 | 0.1% |